STATE STREET CORP - CUBIST PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CUBIST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$290,087,000
+106.8%
2,882,180
+36.3%
0.03%
+93.3%
Q3 2014$140,269,000
-3.1%
2,114,410
+2.0%
0.02%
-6.2%
Q2 2014$144,761,000
-3.1%
2,073,241
+1.5%
0.02%
-5.9%
Q1 2014$149,462,000
-31.2%
2,043,212
-47.2%
0.02%
+21.4%
Q4 2013$217,379,000
+68.9%
3,869,150
+91.1%
0.01%
-12.5%
Q3 2013$128,692,000
+93.2%
2,025,076
+46.8%
0.02%
+77.8%
Q2 2013$66,611,0001,379,0430.01%
Other shareholders
CUBIST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AKANTHOS CAPITAL MANAGEMENT LLC 50,500$3,526,00010.49%
Palo Alto Investors LP 1,526,916$106,609,0007.94%
HealthCor Management, L.P. 1,225,000$85,530,0004.29%
SECTOR GAMMA AS 192,490$13,440,0003.18%
AMI ASSET MANAGEMENT CORP 363,698$25,393,0002.52%
EAGLE BOSTON INVESTMENT MANAGEMENT INC 578,207$40,370,0002.01%
TURNER INVESTMENTS LLC 559,239$39,046,0001.73%
Tekla Capital Management LLC 263,772$18,417,0001.69%
MAZAMA CAPITAL MANAGEMENT INC 80,221$5,601,0001.50%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,234,570$225,838,0001.34%
View complete list of CUBIST PHARMACEUTICALS INC shareholders